Skip to main content

Cyanotic Lesions

  • Chapter
  • First Online:
Pregnancy and Congenital Heart Disease

Abstract

Due to the fact that early childhood repair is now available for almost all forms of cyanotic heart defects, the number of adult women of childbearing age with unrepaired cyanotic defects is constantly decreasing. Adults with unrepaired cyanotic heart defects are, however, a vulnerable patient group with a high risk of morbidity and a high risk of premature death as young adults. The risk of cardiovascular complications during pregnancy and peripartum is high in women with unrepaired cyanotic heart defects. Thorough pre-pregnancy assessment with an aim to identify potential targets for improvement and to allow appropriate risk stratification is important. The offspring risk in women with unrepaired cyanotic heart defects is very high, with premature delivery in more than 40% and low birth weight for gestational age being the most common complications. Successful pregnancies in women with resting oxygen saturation below 85% in room air are exceedingly rare. Detailed pre-pregnancy counselling will enable informed-decision making in affected women. Pregnant women with cyanotic heart defects must be managed by an experienced multi-disciplinary team at a tertiary care centre. The multidisciplinary team should include dedicated cardiologists, high-risk obstetricians and obstetric anaesthetists along with other specialists as needed. A particular emphasis should be put on minimizing preventable complications, such as paradoxical embolism by the use of meticulous thromboembolic prophylaxis at times of increased risk and the use of air bubble filters for all intravenous lines.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

SpO2 :

Transcutaneous oxygen saturation

References

  1. Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39(12):1890–1900

    Article  PubMed  Google Scholar 

  2. Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, Somerville J, Williams RG, Webb GD (2001) Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol 37(5):1170–1175

    Article  CAS  PubMed  Google Scholar 

  3. Greutmann M, Tobler D, Kovacs AH, Greutmann-Yantiri M, Haile SR, Held L, Ivanov J, Williams WG, Oechslin EN, Silversides CK, Colman JM (2015) Increasing mortality burden among adults with complex congenital heart disease. Congenit Heart Dis 10(2):117–127

    Article  PubMed  Google Scholar 

  4. Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M (2014) Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation 130(9):749–756

    Article  PubMed  Google Scholar 

  5. Greutmann M, Pieper PG (2015) Pregnancy in women with congenital heart disease. Eur Heart J 36(37):2491–2499

    Article  PubMed  Google Scholar 

  6. Drenthen W, Boersma E, Balci A, Moons P, Roos-Hesselink JW, Mulder BJ, Vliegen HW, van Dijk AP, Voors AA, Yap SC, van Veldhuisen DJ, Pieper PG, Investigators Z (2010) Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 31(17):2124–2132

    Article  PubMed  Google Scholar 

  7. Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, Kells CM, Bergin ML, Kiess MC, Marcotte F, Taylor DA, Gordon EP, Spears JC, Tam JW, Amankwah KS, Smallhorn JF, Farine D, Sorensen S (2001) Cardiac disease in pregnancy I. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 104(5):515–521

    Article  CAS  PubMed  Google Scholar 

  8. Roos-Hesselink JW, Ruys TP, Stein JI, Thilen U, Webb GD, Niwa K, Kaemmerer H, Baumgartner H, Budts W, Maggioni AP, Tavazzi L, Taha N, Johnson MR, Hall R, Investigators R (2013) Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J 34(9):657–665

    Article  PubMed  Google Scholar 

  9. Presbitero P, Somerville J, Stone S, Aruta E, Spiegelhalter D, Rabajoli F (1994) Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation 89(6):2673–2676

    Article  CAS  PubMed  Google Scholar 

  10. Drenthen W, Pieper PG, Roos-Hesselink JW, van Lottum WA, Voors AA, Mulder BJ, van Dijk AP, Vliegen HW, Yap SC, Moons P, Ebels T, van Veldhuisen DJ, Investigators Z (2007) Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol 49(24):2303–2311

    Article  PubMed  Google Scholar 

  11. Robson SC, Hunter S, Boys RJ, Dunlop W (1989) Hemodynamic changes during twin pregnancy. A Doppler and M-mode echocardiographic study. Am J Obstet Gynecol 161(5):1273–1278

    Article  CAS  PubMed  Google Scholar 

  12. Greutmann M, Von Klemperer K, Brooks R, Peebles D, O’Brien P, Walker F (2010) Pregnancy outcome in women with congenital heart disease and residual haemodynamic lesions of the right ventricular outflow tract. Eur Heart J 31(14):1764–1770

    Article  PubMed  Google Scholar 

  13. Siu SC, Colman JM, Sorensen S, Smallhorn JF, Farine D, Amankwah KS, Spears JC, Sermer M (2002) Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 105(18):2179–2184

    Article  PubMed  Google Scholar 

  14. Burn J, Brennan P, Little J, Holloway S, Coffey R, Somerville J, Dennis NR, Allan L, Arnold R, Deanfield JE, Godman M, Houston A, Keeton B, Oakley C, Scott O, Silove E, Wilkinson J, Pembrey M, Hunter AS (1998) Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 351(9099):311–316

    Article  CAS  PubMed  Google Scholar 

  15. Fesslova V, Brankovic J, Lalatta F, Villa L, Meli V, Piazza L, Ricci C (2011) Recurrence of congenital heart disease in cases with familial risk screened prenatally by echocardiography. J Pregnancy 2011:368067

    Article  PubMed  PubMed Central  Google Scholar 

  16. Gill HK, Splitt M, Sharland GK, Simpson JM (2003) Patterns of recurrence of congenital heart disease: an analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography. J Am Coll Cardiol 42(5):923–929

    Article  PubMed  Google Scholar 

  17. Pieper PG, Balci A, Aarnoudse JG, Kampman MA, Sollie KM, Groen H, Mulder BJ, Oudijk MA, Roos-Hesselink JW, Cornette J, van Dijk AP, Spaanderman ME, Drenthen W, van Veldhuisen DJ, investigators ZI (2013) Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart disease. Circulation 128(23):2478–2487

    Article  CAS  PubMed  Google Scholar 

  18. Wald RM, Silversides CK, Kingdom J, Toi A, Lau CS, Mason J, Colman JM, Sermer M, Siu SC (2015) Maternal cardiac output and fetal doppler predict adverse neonatal outcomes in pregnant women with heart disease. J Am Heart Assoc 4(11)

    Google Scholar 

  19. Tanous D, Siu SC, Mason J, Greutmann M, Wald RM, Parker JD, Sermer M, Colman JM, Silversides CK (2010) B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Cardiol 56(15):1247–1253

    Article  CAS  PubMed  Google Scholar 

  20. Kampman MA, Balci A, van Veldhuisen DJ, van Dijk AP, Roos-Hesselink JW, Sollie-Szarynska KM, Ludwig-Ruitenberg M, van Melle JP, Mulder BJ, Pieper PG, investigators ZI (2014) N-terminal pro-B-type natriuretic peptide predicts cardiovascular complications in pregnant women with congenital heart disease. Eur Heart J 35(11):708–715

    Article  CAS  PubMed  Google Scholar 

  21. Ouyang DW, Khairy P, Fernandes SM, Landzberg MJ, Economy KE (2010) Obstetric outcomes in pregnant women with congenital heart disease. Int J Cardiol 144(2):195–199

    Article  PubMed  Google Scholar 

  22. European Society of G, Association for European Paediatric C, German Society for Gender M, Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JS, Gohlke-Baerwolf C, Gorenek B, Iung B, Kirby M, Maas AH, Morais J, Nihoyannopoulos P, Pieper PG, Presbitero P, Roos-Hesselink JW, Schaufelberger M, Seeland U, Torracca L, Guidelines ESCCfP (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32(24):3147–3197

    Article  Google Scholar 

  23. Saab FG, Aboulhosn JA (2013) Hemodynamic characteristics of cyanotic adults with single-ventricle physiology without Fontan completion. Congenit Heart Dis 8(2):124–130

    Article  PubMed  Google Scholar 

  24. Bedard E, Dimopoulos K, Gatzoulis MA (2009) Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J 30(3):256–265

    Article  PubMed  Google Scholar 

  25. Tobler D, Greutmann M, Colman JM, Greutmann-Yantiri M, Librach LS, Kovacs AH (2012) End-of-life in adults with congenital heart disease: a call for early communication. Int J Cardiol 155(3):383–387

    Article  PubMed  Google Scholar 

  26. Greutmann M, Tobler D, Colman JM, Greutmann-Yantiri M, Librach SL, Kovacs AH (2013) Facilitators of and barriers to advance care planning in adult congenital heart disease. Congenit Heart Dis 8(4):281–288

    Article  PubMed  Google Scholar 

  27. Reid GJ, Webb GD, Barzel M, McCrindle BW, Irvine MJ, Siu SC (2006) Estimates of life expectancy by adolescents and young adults with congenital heart disease. J Am Coll Cardiol 48(2):349–355

    Article  PubMed  Google Scholar 

  28. Thorne S, Nelson-Piercy C, MacGregor A, Gibbs S, Crowhurst J, Panay N, Rosenthal E, Walker F, Williams D, de Swiet M, Guillebaud J (2006) Pregnancy and contraception in heart disease and pulmonary arterial hypertension. J Fam Plann Reprod Health Care 32(2):75–81

    Article  PubMed  Google Scholar 

  29. Silversides CK, Sermer M, Siu SC (2009) Choosing the best contraceptive method for the adult with congenital heart disease. Curr Cardiol Rep 11(4):298–305

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We wish to thank Prof. Jack M. Colman for the thorough review of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthias Greutmann MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Greutmann, M., Tobler, D. (2017). Cyanotic Lesions. In: Roos-Hesselink, J., Johnson, M. (eds) Pregnancy and Congenital Heart Disease. Congenital Heart Disease in Adolescents and Adults. Springer, Cham. https://doi.org/10.1007/978-3-319-38913-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-38913-4_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-38911-0

  • Online ISBN: 978-3-319-38913-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics